These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1810599)

  • 21. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M; Lazzarotti M; Facchini M; Schwartz PJ
    Am Heart J; 1994 Nov; 128(5):973-82. PubMed ID: 7524295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics.
    Mestre M; Djellas Y; Carriot T; Cavero I
    Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.
    Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O
    Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction.
    Thale J; Gülker H; Hindricks G; Haverkamp W; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():107-15. PubMed ID: 3678251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
    Heuer H; Gülker H; Thale J; Bender F
    Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved?
    Kovács M; Kiss A; Gönczi M; Miskolczi G; Seprényi G; Kaszaki J; Kohr MJ; Murphy E; Végh Á
    PLoS One; 2015; 10(4):e0122243. PubMed ID: 25909651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic effects of Org 7797, a new steroidal antiarrhythmic agent: comparison with class 1a, 1b, and 1c drugs.
    Winslow E; Martorana M; Bell P
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):205-12. PubMed ID: 2476592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF
    Presse Med; 1985 Mar; 14(12):685-9. PubMed ID: 3157964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
    Faucon G; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Larbre JP; Timour Q
    Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
    Galimberti ES; Knollmann BC
    J Mol Cell Cardiol; 2011 Nov; 51(5):760-8. PubMed ID: 21798265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
    Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B
    Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    Slawsky MT; Castle NA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia or reperfusion in anaesthetized rats.
    Barnes CS; Coker SJ
    Br J Pharmacol; 1995 Jan; 114(2):349-56. PubMed ID: 7881734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
    Allan G; Donoghue S; Follenfant MJ; Sawyer DA
    Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifibrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide.
    Usui M; Inoue H; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):376-83. PubMed ID: 7681497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.